Bruno Giometto
Clinica Neurologica II
Via Vendramini, 7
35137 Padova
Italy
Tel : ++39 049 8216346
Fax: ++39 049 8216358
Dr. Bruno Giometto was born in 1956. He has worked as a Consultant at
the Department of Neurological and Psychiatric Sciences (Second Clinic)
at University of Padova, Italy, and has recently been appointed as chief
of Service of Neurology at the Hospital of Treviso (Italy). He has longstanding
experience in clinical neuro-immunology and neuropathology and has spent
periods as a fellow at the Dept. of Neuropathology, Institute of Neurology,
University College London, London (UK). He is coordinator of a research
group that studies immunopathological mechanisms in neurological diseases
in the Neuro-Immunology laboratory of the University of Padova. This
laboratory keeps a serum and cerebrospinal fluid bank (CSF-bank) in
which several aliquots of serum and CSF from patients with autoimmune
and transmissible neurological disorders are stored. Since 2002, he
has coordinated a Concerted Action funded by the European Commission,
involving members from 12 European countries, to study paraneoplastic
neurological disorders.
Scientific Team
Scientists involved: Prof. B. Tavolato, Dr. P. Nicolao, Dr. AM Ferrarini,
Dr. M. Vianello, Dr. R. Vitaliani, Dr. R Pezzani and Dr. L Zuliani (Dept.
of Neurology, University of Padova).
Research facilities
Immunohistochemistry and immunoblot techniques to detect
onconeural antibodies.
Selected Publications:
1. Vincent A., Honnorat J., Antoine JC., Giometto B., Dalmau J., Lang
B. Autoimmunity in paraneoplastic neurological disorders. J
Neuroimmunol , 84, 105-109, 1998.
2. Giometto B., Tavolato B, Graus F. Autoimmunity in Paraneoplastic
Neurological Syndromes. Brain
Pathol, 9, 261-274, 1999.
3. Vigliani MC, Polo P, Chiò A, Giometto B, Mazzini L, Schiffer
D. Patients with amyotrophic lateral sclerosis and cancer do not clinically
differ from patients with classical amyotrophic lateral sclerosis. J
Neurol, 247, 778-782, 2000.
4. Honnorat J, Saiz A, Giometto B, et al Anti-Glutamic acid decarboxilase
antibodies identifies a group of patients with late-onset cerebellar
ataxia and polyendocrine autoimmunity. Arch
Neurol, 58, 225-230, 2001.
5. Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase
autoantibodies and neurological disorders. Neurol
Sci 23: 145-151, 2002.
6. Vianello M, Morello F, Scaravilli T, Tavolato B, Giometto B. Tremor
of the mouth floor and anti-glutamic acid decerboxylase autoantibodies
Eur.
J. Neurol, 10: 513-514, 2003

|